B. Hemalatha, M. Kalpana, B. Sree Rekha, A. Varalakshmi, K. Padmalatha
B. Hemalatha1*, M. Kalpana1, B. Sree Rekha1, A. Varalakshmi1, K. Padmalatha2
1Department of Pharmaceutics, Vijaya Institute of Pharmaceutical Sciences for Women, Vijayawada.
2Department of Pharmacology, Vijaya Institute of Pharmaceutical Sciences for Women, Vijayawada.
Volume - 12,
Issue - 3,
Year - 2022
Nasal drug delivery has got a great deal of attention as a convenient, reliable and potential method for the systemic administration of drugs. It is specially for those molecules which are ineffective orally and only effective if given by injection. The nasal route of drug delivery has advantages over the other alternative systems of non-invasive drug administration. Nasal route is advantageous for the drugs which are unstable on oral administration as they are much degraded in GIT or else metabolized by first pass effect in liver. Nasal route is alternative to parenteral therapy and as well helpful for long term therapy. Nasal mucosa is greatly vascularised as well as mainly permeable giving fast absorption and onset of action. Nasal route is non invasive, extensively used for the local treatment might also be used for systemic therapy as drug directly goes in systemic circulation. Nasal route gives excellent absorption of small molecules, than that of large molecules can be augmented by absorption promoters. The present review presents information pertaining to nasal drug delivery system such as advantages, limitations, anatomy of nose, mechanism of drug absorption, barriers to drug absorption, factors influencing nasal drug absorption, strategies to improve nasal absorption, excipients used in nasal formulations, nasal formulations and their evaluation.
Cite this article:
B. Hemalatha, M. Kalpana, B. Sree Rekha, A. Varalakshmi, K. Padmalatha. An Overview on Nasal Drug Delivery System. Asian Journal of Pharmaceutical Research. 2022; 12(3):249-8. doi: 10.52711/2231-5691.2022.00041
B. Hemalatha, M. Kalpana, B. Sree Rekha, A. Varalakshmi, K. Padmalatha. An Overview on Nasal Drug Delivery System. Asian Journal of Pharmaceutical Research. 2022; 12(3):249-8. doi: 10.52711/2231-5691.2022.00041 Available on: https://www.asianjpr.com/AbstractView.aspx?PID=2022-12-3-12
1. Sulaiman Alnasser. A review on nasal drug delivery system and its contribution in therapeutic management. Asian J Pharm Clin Res 2019; 12 (1): 40 - 45.
2. Sachin Chhajed, Sagar Sangale and S.D. Barhate. Advantageous nasal drug delivery system: A review International Journal of Pharmaceutical Sciences and Research 2011; 2(6): 1322 - 1336.
3. Martha Srinivas, Kalyani Y, JVC Sharma. A Promising Drug Delivery: Intranasal Drug Delivery System. Int. J. Pharm. Sci. Rev. Res., 2021; 69(1): 145-154.
4. M. Alagusundaram, B. Chengaiah, K. Gnanaprakash, S. Ramkanth, C. Madhusudhana Chetty, D. Dhachinamoorthi. Nasal drug delivery system - An overview. Int. J. Res. Pharm. Sci. 2010; 1(4): 454 - 465.
5. Muhammad U. Ghori, Mohammed H. Mahdi, Alan M. Smith, Barbara R. Conway. Nasal Drug Delivery Systems: An Overview. American Journal of Pharmacological Sciences 2015; 3(5): 110 – 119.
6. Pagar Swati Appasaheb, Shinkar Dattatraya Manohar, Saudagar Ravindra Bhanudas. A Review on Intranasal Drug Delivery System. Journal of Advanced Pharmacy Education & Research 2013; 3 (4): 333 - 346.
7. Prajapati M., Mandloi R., Pillai S, Birla N. The review on the nasal drug delivery. Asian Journal of Pharmaceutical Research 2015; 3 (5): 110 – 119.
8. Akash H. Mali, Azam Z. Shaikh. A Short Review on Nasal Drug Delivery System. Asian Journal of Pharmacy and Technology 2021; 11(4): 289-2.
9. Surbhi Verma, Yogita Tyagi, Pranshu Tangri. Review article on nasal drug delivery system. International Journal of Scientific Development and Research 2021; 6 (2): 100 – 107.
10. Lea‑Adriana Keller, Olivia Merkel, Andreas Popp. Intranasal drug delivery: opportunities and toxicologic challenges during drug development. Drug Delivery and Translational Research 2021; 1 – 23.
11. Parmar Harshad, Bhandari Anand, Shah Dushyant. Recent techniques in nasal drug delivery: A review. Int. J. Drug Dev. & Res., 2010; 2(3): 565 - 572.
12. Nirav S Sheth, Rajan B Mistry. A Review: Nasal Drug Delivery System. Research J. Pharm. and Tech. 2011; 4(3): 349 - 355.
13. Shanu T, Nitin S, Sharma PK. A review on application of natural bio adhesive polysaccharides for intranasal drug delivery. Int J A.PS.BMS 2012; 1: 80 - 94.
14. Zaheer A, Swamy S. Mucoadhesive polymers: Drug carriers for improved nasal drug delivery. Indian J Novel Drug Deliv 2012; 4: 2 - 16.
15. Mahalaxmi R, Kumar DS, Shirwaikar A. preparation of mucoadhesive microsphere for nasal delivery by spray drying. Indian J Pharm Sci 2007; 69: 651 - 657.
16. Varshosaz J, Sadrai H, Heidari A. Nasal delivery of insulin using bioadhesive chitosan gels. Drug Deliv 2006; 13: 31 - 38.
17. Patil SB, Sawant KK. Development, optimization and in vitro evaluation of alginate mucoadhesive microspheres of carvedilol for nasal delivery. J Microencapsul 2009; 26: 432 - 443.
18. Ding WX, Qi XR, Fu Q, Piao HS. Pharmacokinetics and pharmacodynamics of sterylglucoside-modified liposomes for levonorgestrel delivery via nasal route. Drug Deliv 2007; 14: 101 - 104.
19. Costantino HR, Illum L, Brandt G, Johnson PH, Quay SC. Intranasal delivery: Physicochemical and therapeutic aspects. Int J Pharm 2007; 337: 1 - 24.
20. Illum L. Transport of drugs from the nasal cavity to the central nervous system. Eur J Pharm Sci 2000; 11: 1 - 8.
21. Kritika S, Bhupen K, Banasmita K. Development and characterization of mucoadhesive microsphere-loaded intranasal gel of venlafaxine hydrochloride. Asian J Pharm Clin Res 2016; 9: 139 - 44.
22. Shah ND, Shah VV, Chivate ND. Pulmonary Drug Delivery: A Promising Approach. Journal of Applied Pharmaceutical Science 2012; 02(06): 33-37.
23. Siraj sheikh. Recent trends in applications of pulmonary drug delivery: A review. International Journal of Pharma Research and Development 2011; 2(12): 018.
24. KarhaleAshish A, ChaudhariHiralal S, UghadePrajkta L, BaviskarDheeraj T, Jain Dinesh K. Pulmonary Drug Delivery System. International Journal of PharmTech Research 2012; 4(1): 293 - 305.
25. Kublik H, Vidgren M.T. Nasal delivery systems and their effect on deposition and absorption. Advanced Drug Delivery Reviews 1998; 29: 157 – 177.
26. Graff L.C., Pollock G.M. Nasal drug administration: potential for targeted central nervous system delivery. J Pharm Sci. 2005; 94: 1187 - 1195.
27. Singh kumar Arun.Nasal cavity: A promising transmucosal platform for drug delivery and research approach from nasal to brain targeting. Journal of Drug Delivery and Therapeutics 2012; 23: 22 - 33.
28. Gannu Praveen Kumar and Kiran S. Strategies and prospects of nasal drug delivery systems. Indian Journal of Pharmaceutical Science & Research. 2012; 2(1): 33 - 41.
29. Cornaz A.L., and Buri P. Nasal mucosa as an absorption barrier. Eur. J. Pharm. Biopharm. 1994; 40: 261–270.
30. Parvathi M. Intranasal drug delivery to brain: an overview. International journal of research in pharmacy and chemistry 2012; 2(3): 889 - 895.
31. Arora P, Sharma, Gary S. Permeability issues in nasal drug delivery. Drug Discov Today 2002; 7: 967–975.